home All News open_in_new Full Article

Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel

VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce the appointments of Mr. Yevgeniy Meshcherekov and Dr. David Kideckel to the Company’s board of directors (the “Board”), subject to receiving approval […]


today 9 h. ago attach_file Society

attach_file Society
attach_file Society
attach_file Other
attach_file Economics
attach_file Other
attach_file Other
attach_file Politics
attach_file Other
attach_file Politics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Events
attach_file Politics
attach_file Other
attach_file Other
attach_file Other


ID: 2892129208
Add Watch Country

arrow_drop_down